Related Experiment Video
Updated: May 5, 2026

Fast and Specific Assessment of the Halogenating Peroxidase Activity in Leukocyte-enriched Blood Samples
Published on: July 28, 2016
Association between myeloperoxidase levels and risk of coronary artery disease
1Department of Cell Biology, Cleveland Clinic Foundation, 9500 Euclid Ave, NC-10, Cleveland, OH 44195, USA.
Context:
Myeloperoxidase (MPO), a leukocyte enzyme that promotes oxidation of lipoproteins in atheroma, has been proposed as a possible mediator of atherosclerosis.
Objective:
To determine the association between MPO levels and prevalence of coronary artery disease (CAD).
Design, Setting, And Patients:
Case-control study conducted from July to September 2000 in a US tertiary care referral center, including 158 patients with established CAD (cases) and 175 patients without angiographically significant CAD (controls).
Main Outcome Measures:
Association of MPO levels per milligram of neutrophil protein (leukocyte-MPO) and MPO levels per milliliter of blood (blood-MPO) with CAD risk.
Results:
Leukocyte- and blood-MPO levels were both significantly greater in patients with CAD than in controls (P<.001). In multivariable models adjusting for traditional cardiovascular risk factors, Framingham risk score, and white blood cell counts, MPO levels were significantly associated with presence of CAD, with an OR of 11.9 (95% CI, 5.5-25.5) for the highest vs lowest quartiles of leukocyte-MPO and an OR of 20.4 (95% CI, 8.9-47.2) for the highest vs lowest quartiles of blood-MPO.
Conclusions:
Elevated levels of leukocyte- and blood-MPO are associated with the presence of CAD. These findings support a potential role for MPO as an inflammatory marker in CAD and may have implications for atherosclerosis diagnosis and risk assessment.
Insights
Elevated myeloperoxidase (MPO) levels in blood and leukocytes are strongly associated with coronary artery disease (CAD). This suggests MPO may be a key inflammatory marker for diagnosing and assessing atherosclerosis risk.
Area of Science:
- Cardiovascular Research
- Biomarker Discovery
- Inflammation Studies
Background:
- Myeloperoxidase (MPO) is a leukocyte enzyme implicated in lipoprotein oxidation within atheromas.
- MPO's role as a potential mediator in the development of atherosclerosis has been previously suggested.
Purpose of the Study:
- To investigate the association between myeloperoxidase (MPO) levels and the prevalence of coronary artery disease (CAD).
Main Methods:
- A case-control study was conducted involving 158 patients with established CAD and 175 controls without significant CAD.
- MPO levels were measured per milligram of neutrophil protein (leukocyte-MPO) and per milliliter of blood (blood-MPO).
- Associations with CAD risk were analyzed using multivariable models, adjusting for cardiovascular risk factors.
Main Results:
- Both leukocyte-MPO and blood-MPO levels were significantly higher in patients with CAD compared to controls (P<.001).
- Adjusted analyses revealed significant associations between MPO levels and CAD presence.
- The highest quartiles of leukocyte-MPO and blood-MPO showed odds ratios of 11.9 and 20.4, respectively, for CAD.
Conclusions:
- Elevated leukocyte-MPO and blood-MPO levels are significantly associated with the presence of coronary artery disease.
- These findings support MPO's role as an inflammatory marker in CAD.
- MPO may hold implications for improving atherosclerosis diagnosis and risk stratification.
Related Concept Videos
Peroxisomes
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies

